HI
AGN

HBK Investments’s Allergan plc AGN Stock Holding History

HBK Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,600
Closed -$360K – 1199
2019
Q1 		$381K Sell
2,600
-142,535
-98% -$20.7M ﹤0.01% 886
2018
Q4 		$19.4M Buy
145,135
+143,629
+9,537% +$23.5M 0.21% 76
2018
Q3 		$287K Buy
+1,506
New +$277K ﹤0.01% 1059
2018
Q1 		– Sell
-93,057
Closed -$15.2M – 1206
2017
Q4 		$15.2M Buy
93,057
+88,757
+2,064% +$15.9M 0.12% 101
2017
Q3 		$881K Buy
+4,300
New +$1,000K 0.01% 666
2015
Q2 		– Sell
-9,372
Closed -$2.79M – 1161
2015
Q1 		$2.79M Buy
+9,372
New +$2.67M 0.03% 337
2014
Q3 		– Sell
-4,621
Closed -$1.03M – 1130
2014
Q2 		$1.03M Buy
+4,621
New +$957K 0.02% 510
2013
Q4 		– Sell
-26,311
Closed -$3.79M – 1054
2013
Q3 		$3.79M Buy
+26,311
New +$3.5M 0.06% 186

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HBK Investments's AGN Position: Q2 2019 in Review

HBK Investments sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,600 shares — an estimated $360K sold.

HBK Investments first reported a position in AGN in Q3 2013 and held it in 8 quarters. The position peaked at $19.4M in Q4 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • HBK Investments reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 2,600 Allergan plc shares in Q2 2019, an estimated $360K.
  • HBK Investments first reported a position in Allergan plc in Q3 2013 and held it in 8 quarters.
  • HBK Investments's Allergan plc position peaked at $19.4M in Q4 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.